|
1
|
Zhu Z, Yan J, Jiang W, Yao XG, Chen J,
Chen L, Li C, Hu L, Jiang H and Shen X: Arctigenin effectively
ameliorates memory impairment in Alzheimer's disease model mice
targeting both β-amyloid production and clearance. J Neurosci.
33:13138–13149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Terry RD, Masliah E, Salmon DP, Butters N,
DeTeresa R, Hill R, Hansen LA and Katzman R: Physical basis of
cognitive alterations in Alzheimer's disease: synapse loss is the
major correlate of cognitive impairment. Ann Neurol. 30:572–580.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi SM, Kim BC, Cho YH, Choi KH, Chang J,
Park MS, Kim MK, Cho KH and Kim JK: Effects of flavonoid compounds
on β-amyloid-peptide-induced neuronal death in cultured mouse
cortical neurons. Chonnam Med J. 50:45–51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marcus DL, Thomas C, Rodriguez C,
Simberkoff K, Tsai JS, Strafaci JA and Freedman ML: Increased
peroxidation and reduced antioxidant enzyme activity in Alzheimer's
disease. Exp Neurol. 150:40–44. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng L, Kågedal K, Dehvari N, Benedikz E,
Cowburn R, Marcusson J and Terman A: Oxidative stress induces
macroautophagy of amyloid beta-protein and ensuing apoptosis. Free
Radic Biol Med. 46:422–429. 2009. View Article : Google Scholar
|
|
6
|
Behl C and Holsboer F: Oxidative stress in
the pathogenesis of Alzheimer's disease and antioxidant
neuroprotection. Fortschr Neurol Psychiatr. 66:113–121. 1998.In
German. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng QL, Buz'Zard AR and Lau BH:
Pycnogenol protects neurons from amyloid-beta peptide-induced
apoptosis. Brain Res Mol Brain Res. 104:55–65. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andersen JK: Oxidative stress in
neurodegeneration: cause or consequence? Nat Med. 10(Suppl):
S18–S25. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Butterfield DA, Perluigi M and Sultana R:
Oxidative stress in Alzheimer's disease brain: New insights from
redox proteomics. Eur J Pharmacol. 545:39–50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aliev G, Obrenovich ME, Reddy VP, Shenk
JC, Moreira PI, Nunomura A, Zhu X, Smith MA and Perry G:
Antioxidant therapy in Alzheimer's disease: theory and practice.
Mini Rev Med Chem. 8:1395–1406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin YH, Liu AH, Wu HL, Westenbroek C, Song
QL, Yu HM, Ter Horst GJ and Li XJ: Salvianolic acid B, an
antioxidant from Salvia miltiorrhiza, prevents Abeta(25–35)-induced
reduction in BPRP in PC12 cells. Biochem Biophys Res Commun.
348:593–599. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Merken HM and Beecher GR: Measurement of
food flavonoids by high-performance liquid chromatography: A
review. J Agric Food Chem. 48:577–599. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rice-Evans CA, Miller NJ and Paganga G:
Structure-antioxidant activity relationships of flavonoids and
phenolic acids. Free Radic Biol Med. 20:933–956. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng LH, Zhang HD, Xu CJ, Bian YJ, Xu XJ,
Xie QM and Zhang RH: Neuroprotective effects of flavonoids
extracted from licorice on kainate-induced seizure in mice through
their antioxidant properties. J Zhejiang Univ Sci B. 14:1004–1012.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dugas AJ Jr, Castañeda-Acosta J, Bonin GC,
Price KL, Fischer NH and Winston GW: Evaluation of the total
peroxyl radical-scavenging capacity of flavonoids:
Structure-activity relationships. J Nat Prod. 63:327–331. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho JG, Song NY, Nam TG, Shrestha S, Park
HJ, Lyu HN, Kim DO, Lee G, Woo YM, Jeong TS, et al: Flavonoids from
the grains of C1/R-S transgenic rice, the transgenic Oryza sativa
spp. japonica, and their radical scavenging activities. J Agric
Food Chem. 61:10354–10359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nijveldt RJ, van Nood E, van Hoorn DE,
Boelens PG, van Norren K and van Leeuwen PA: Flavonoids: a review
of probable mechanisms of action and potential applications. Am J
Clin Nutr. 74:418–425. 2001.PubMed/NCBI
|
|
18
|
Thilakarathna SH and Rupasinghe HP:
Flavonoid bioavailability and attempts for bioavailability
enhancement. Nutrients. 5:3367–3387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beking K and Vieira A: Flavonoid intake
and disability-adjusted life years due to Alzheimer's and related
dementias: a population-based study involving twenty-three
developed countries. Public Health Nutr. 13:1403–1409. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Letenneur L, Proust-Lima C, Le Gouge A,
Dartigues JF and Barberger-Gateau P: Flavonoid intake and cognitive
decline over a 10-year period. Am J Epidemiol. 165:1364–1371. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu X, Zhang J, Guo L, Xu Y, Sun L, Wang S,
Feng Y, Gou L, Zhang L and Liu Y: Protective role of luteolin
against cognitive dysfunction induced by chronic cerebral
hypoperfusion in rats. Pharmacol Biochem Behav. 126:122–130. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Fu X, Lan N, Li S, Zhang J, Wang S,
Li C, Shang Y, Huang T and Zhang L: Luteolin protects against high
fat diet-induced cognitive deficits in obesity mice. Behav Brain
Res. 267:178–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rezai-Zadeh K, Douglas Shytle R, Bai Y,
Tian J, Hou H, Mori T, Zeng J, Obregon D, Town T and Tan J:
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's
disease beta-amyloid production. J Cell Mol Med. 13:574–588. 2009.
View Article : Google Scholar :
|
|
24
|
Zhou F, Chen S, Xiong J, Li Y and Qu L:
Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in
an ROS-dependent manner in SH-SY5Y cells. Biol Trace Elem Res.
149:273–279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sawmiller D, Li S, Shahaduzzaman M, Smith
AJ, Obregon D, Giunta B, Borlongan CV, Sanberg PR and Tan J:
Luteolin reduces Alzheimer's disease pathologies induced by
traumatic brain injury. Int J Mol Sci. 15:895–904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharifzadeh M, Naghdi N, Khosrovani S,
Ostad SN, Sharifzadeh K and Roghani A: Post-training
intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired
spatial memory retention in rats. Eur J Pharmacol. 511:159–166.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tabrizian K, Najafi S, Belaran M,
Hosseini-Sharifabad A, Azami K, Hosseini A, Soodi M, Kazemi A,
Abbas A and Sharifzadeh M: Effects of selective iNOS inhibitor on
spatial memory in recovered and non-recovered ketamine
induced-anesthesia in wistar rats. Iran J Pharm Res. 9:313–320.
2010.PubMed/NCBI
|
|
28
|
Shimoi K, Masuda S, Furugori M, Esaki S
and Kinae N: Radioprotective effect of antioxidative flavonoids in
gamma-ray irradiated mice. Carcinogenesis. 15:2669–2672. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seelinger G, Merfort I and Schempp CM:
Anti-oxidant, anti-inflammatory and anti-allergic activities of
luteolin. Planta Med. 74:1667–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yasukawa K, Takido M, Takeuchi M and
Nakagawa S: Effect of chemical constituents from plants on
12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.
Chem Pharm Bull (Tokyo). 37:1071–1073. 1989. View Article : Google Scholar
|
|
31
|
Majumdar D, Jung KH, Zhang H, Nannapaneni
S, Wang X, Amin AR, Chen Z, Chen ZG and Shin DM: Luteolin
nanoparticle in chemoprevention: in vitro and in vivo anticancer
activity. Cancer Prev Res (Phila). 7:65–73. 2014. View Article : Google Scholar
|
|
32
|
Ferriola PC, Cody V and Middleton E Jr:
Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms
and structure-activity relationships. Biochem Pharmacol.
38:1617–1624. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nekohashi M, Ogawa M, Ogihara T, Nakazawa
K, Kato H, Misaka T, Abe K and Kobayashi S: Luteolin and quercetin
affect the cholesterol absorption mediated by epithelial
cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and
rats. PLoS One. 9:e979012014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bast A, Kaiserová H, den Hartog GJ, Haenen
GR and van der Vijgh WJ: Protectors against doxorubicin-induced
cardiotoxicity: Flavonoids. Cell Biol Toxicol. 23:39–47. 2007.
View Article : Google Scholar
|
|
35
|
Salkovic-Petrisic M and Hoyer S: Central
insulin resistance as a trigger for sporadic Alzheimer-like
pathology: an experimental approach. J Neural Transm Suppl.
72:217–233. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grünblatt E, Salkovic-Petrisic M,
Osmanovic J, Riederer P and Hoyer S: Brain insulin system
dysfunction in streptozotocin intracerebroventricularly treated
rats generates hyperphosphorylated tau protein. J Neurochem.
101:757–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maiese K and Chong ZZ: Insights into
oxidative stress and potential novel therapeutic targets for
Alzheimer disease. Restor Neurol Neurosci. 22:87–104.
2004.PubMed/NCBI
|
|
38
|
Behl C, Davis JB, Lesley R and Schubert D:
Hydrogen peroxide mediates amyloid beta protein toxicity. Cell.
77:817–827. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Varadarajan S, Yatin S, Kanski J,
Jahanshahi F and Butterfield DA: Methionine residue 35 is important
in amyloid beta-peptide-associated free radical oxidative stress.
Brain Res Bull. 50:133–141. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sharma M and Gupta YK:
Intracerebroventricular injection of streptozotocin in rats
produces both oxidative stress in the brain and cognitive
impairment. Life Sci. 68:1021–1029. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Selkoe DJ: Alzheimer's disease: Genes,
proteins, and therapy. Physiol Rev. 81:741–766. 2001.PubMed/NCBI
|
|
42
|
Rasoolijazi H, Joghataie MT, Roghani M and
Nobakht M: The beneficial effect of (−)-epigallocatechin-3-gallate
in an experimental model of Alzheimer's disease in rat: a
behavioral analysis. Iran Biomed J. 11:237–243. 2007.
|
|
43
|
Gilgun-Sherki Y, Rosenbaum Z, Melamed E
and Offen D: Antioxidant therapy in acute central nervous system
injury: current state. Pharmacol Rev. 54:271–284. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Subramaniam R, Koppal T, Green M, Yatin S,
Jordan B, Drake J and Butterfield DA: The free radical antioxidant
vitamin E protects cortical synaptosomal membranes from amyloid
beta-peptide (25–35)toxicity but not from hydroxynonenal toxicity:
relevance to the free radical hypothesis of Alzheimer's disease.
Neurochem Res. 23:1403–1410. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu D, Li M, Tian Y, Liu J and Shang J:
Luteolin inhibits ROS-activated MAPK pathway in myocardial
ischemia/reperfusion injury. Life Sci. 122:15–25. 2015. View Article : Google Scholar
|
|
46
|
Pratheeshkumar P, Son YO, Divya SP, Roy
RV, Hitron JA, Wang L, Kim D, Dai J, Asha P, Zhang Z, et al:
Luteolin inhibits Cr(VI)-induced malignant cell transformation of
human lung epithelial cells by targeting ROS mediated multiple cell
signaling pathways. Toxicol Appl Pharmacol. 281:230–241. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xia F, Wang C, Jin Y, Liu Q, Meng Q, Liu K
and Sun H: Luteolin protects HUVECs from TNF-α-induced oxidative
stress and inflammation via its effects on the Nox4/ROS-NF-κB and
MAPK pathways. J Atheroscler Thromb. 21:768–783. 2014. View Article : Google Scholar
|
